Vesicular Stomatitis Virus (VSV) Engineered to Express CD19 Stimulates Anti-CD19 Chimeric Antigen Receptor Modified T Cells and Promotes Their Anti-Tumor Effects
Year: 2020
Type: article
Source: Blood
Authors: Reona Sakemura, Elizabeth C. Eckert, Sydney B. Crotts, Linh Pham, Elizabeth L. Siegler, Michelle J. Cox, Erin E. Tapper, Mehrdad Hefazi, Claudia Manriquez Roman, Kendall J. Schick, Ismail Can, Evandro D. Bezerra, Lionel Kankeu Fonkoua, Paulina Horvei, Michael W. Ruff, Susan L. Slager, Sameer A. Parikh, Neil E. Kay, Kah-Whye Peng, Stephen J. Russell, Saad S. Kenderian
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3095495704